Targeting RGS4 Ablates Glioblastoma Proliferation
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21093300
Abstract: Glioblastoma (GBM) is the most common type of adult primary brain tumor with a median survival rate of less than 15 months, regardless of the current standard of care. Cellular heterogeneity, self-renewal ability and tumorigenic… read more here.
Keywords: silencing rgs4; rgs4; targeting rgs4; ablates glioblastoma ... See more keywords